Predicting Treatment Response of Malignant Gliomas to Bevacizumab and Irinotecan by Imaging Proliferation With [<sup>18</sup>F] Fluorothymidine Positron Emission Tomography: A Pilot StudyWei Chen, Timothy F. Cloughesy, Nagichettiar Satyamurthy et al.|Journal of Clinical Oncology|2007Cited by 391
Treatment Response Evaluation Using 18F-FDOPA PET in Patients with Recurrent Malignant Glioma on Bevacizumab TherapyJ. von Schwarzenberg, Wei Chen, Johannes Czernin et al.|Clinical Cancer Research|2014Cited by 140
3′-Deoxy-3′-<sup>18</sup>F-Fluorothymidine PET and MRI for Early Survival Predictions in Patients with Recurrent Malignant Glioma Treated with BevacizumabJ. von Schwarzenberg, Wei Chen, Michael E. Phelps et al.|Journal of Nuclear Medicine|2011Cited by 133